Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
2014 · Nature Communications · 890 citations
https://doi.org/10.1038/ncomms3997
A
Adam S. Sperling
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
329
Papers
5.9K
Citations
34
h-index
59
i10-index
Adam S. Sperling is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Acute Myeloid Leukemia Research & CAR-T cell therapy research. The author has an h-index of 34, co-authored 280 publications.
ORCID: 0000-0002-9369-4413Papers by this author
worksClonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
2020 · Nature Communications · 160 citations
https://doi.org/10.1038/s41467-020-16805-5
Widespread intronic polyadenylation diversifies immune cell transcriptomes
2018 · Nature Communications · 152 citations
https://doi.org/10.1038/s41467-018-04112-z
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
2025 · Journal of Clinical Oncology · 76 citations
https://doi.org/10.1200/jco-24-01893
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy
2023 · Blood · 38 citations
https://doi.org/10.1182/blood.2023020331
Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy
2023 · Blood Advances · 35 citations
https://doi.org/10.1182/bloodadvances.2023010524
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat